Search

Displaying results 531 - 540 of 8010 in total
  1. Drug

    Lutropin alfa

    go.drugbank.com/drugs/DB00044
    ApprovedInvestigational

    Lutropin alfa was the first and only recombinant human form of luteinizing hormone (LH) developed for use in the stimulation of follicular development. … It is a heterodimeric glycoprotein made up of monomeric units.

    Mixtures: Pergoveris 150IU/75IU powder and solvent for solution for injection, Pergoveris Powder and Solvent for Solution for Injection 150iu/75iuProducts: LUVERIS FOR INJECTION 75 iu/vial (Revised formula)
  2. Drug

    Daptomycin

    go.drugbank.com/drugs/DB00080
    ApprovedInvestigational

    [A231374, L32534] Daptomycin was first discovered in the early 1980s by researchers at Eli Lilly in soil samples from Mount Ararat in Turkey. … [A231384] Early work on developing daptomycin was abandoned due to observed myopathy but was resumed in 1997 when Cubist Pharmaceuticals Inc. licensed daptomycin; it was found that a once-daily dosing

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: DAPTOCCORD 500 POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500 MG/VIAL, Daptomycin for Injection
  3. Drug

    Melphalan

    go.drugbank.com/drugs/DB01042
    ApprovedInvestigational

    [L40928] It was first synthesized in the early 1950s by substituting L-phenylalanine for the methyl group on nitrogen mustard. … [L40928] It is also used for high-conditioning before hematopoietic stem cell transplant.[L47890] It is also used to treat uveal melanoma with unresectable hepatic metastases.[L47895]

    Mixtures: Melphalan for Injection, Melphalan for InjectionProducts: Melphalan for Injection, ALKERAN FOR INJECTION 50 mg/vial
  4. Drug

    Moxifloxacin

    go.drugbank.com/drugs/DB00218
    ApprovedInvestigational

    Bayer AG developed the drug (initially called BAY 12-8039) and it is marketed worldwide (as the hydrochloride) under the brand name Avelox (in some countries also Avalox) for oral treatment.

    Mixtures: TQ OFTAMOX D UD®, TQ OFTAMOX® D UDCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  5. Drug

    Docetaxel

    go.drugbank.com/drugs/DB01248
    ApprovedInvestigational

    [L46466] Docetaxel was approved by the FDA in 1996 and is available in solution for injection for intravenous or parenteral administration.[A259676] … Docetaxel binds to microtubules but does not interact with dimeric tubulin.

    Products: Taxotere 20mg/1ml concentrate for solution for infusion, Daxotel Concentrate for Solution for Infusion 20mg/ml
  6. Drug

    Ferrous sulfate anhydrous

    go.drugbank.com/drugs/DB13257
    ApprovedInvestigational

    It is the gold standard of oral iron therapy in the UK and many other countries.[L2234,L2246]

    International brands: Vitafer-FolMixtures: TL-Fol 500, TARDYFERON FOL
  7. Drug

    Ixabepilone

    go.drugbank.com/drugs/DB04845
    ApprovedInvestigational

    It was FDA approved on October 16, 2007, for the treatment of unresponsive aggressive metastatic or locally advanced breast cancer. … Ixabepilone is an epothilone B analog developed by Bristol-Myers Squibb as a cancer drug.

    Products: IXEMPRA FOR INJECTION 15 MG, IXEMPRA (FOR INJECTION 15 MG)
  8. Drug

    Human immunoglobulin G

    go.drugbank.com/drugs/DB00028
    ApprovedInvestigational

    Intravenous immunoglobulin (IVIg) is a mixture of IgG1 and other antibodies derived from healthy human plasma via Cohn fractionation. … IVIg contains the same distribution of IgG antibody subclasses as is found in the general human population.

    Products: GAMMAGARD S/D FOR INJECTION, -C SOLUTION FOR INFUSION 10%
  9. Drug

    Docusate

    go.drugbank.com/drugs/DB11089
    Approved

    Docusate, or dioctyl sulfosuccinate, is a stool softener indicated for the treatment of constipation[A32201]. … Docusate acts by increasing the amount of water the stool absorbs in the gut, making the stool softer and easier to pass [L1801]. Docusate can be orally or rectally administered.

    Categories: Drugs for ConstipationProducts: Up and up stool softener
  10. Drug

    Enoxaparin

    go.drugbank.com/drugs/DB01225
    ApprovedInvestigational

    Initially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies.

    Products: CLEXANE 6000 IU (60 mg) / 0.6 ML (PREFILLED SYRINGE FOR INJECTION), CLEXANE 4000 IU (40 mg) / 0.4 ML (PREFILLED SYRINGE FOR INJECTION)